Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,984,510
-$1,518,793 QoQ
Shares Held
31,538
-20.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#633
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KESTRA PRIVATE WEALTH SERVICES, LLC holds $235,896,515 across 13 Drug Manufacturers - General names. GILD ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
56,415 | $67,665,849 | |
| 2 | ABBV |
AbbVie Inc.
|
180,625 | $45,452,475 | |
| 3 | MRK |
Merck & Co., Inc.
|
256,709 | $32,987,106 | |
| 4 | JNJ |
Johnson & Johnson
|
126,054 | $32,013,934 | |
| 5 | AMGN |
Amgen Inc
|
79,392 | $28,749,431 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
151,030 | $8,702,348 | |
| 7 | PFE |
Pfizer Inc
|
297,975 | $7,175,238 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
31,538 | $3,984,510 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,984,510 | 31,538 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,503,303 | 39,487 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,209,699 | 42,445 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,533,351 | 40,841 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,894,863 | 35,130 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,316,231 | 29,596 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,712,722 | 29,368 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,357,664 | 28,121 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,401,144 | 34,997 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,091,076 | 42,199 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,778,711 | 46,645 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,951,736 | 39,388 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,933,977 | 38,069 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,942,365 | 35,463 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,003,223 | 23,334 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $1,568,838 | 25,431 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,801,267 | 29,142 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,894,790 | 31,872 | Shares | Sole | 2022-07-21 | |
| 2021-12-31 | $1,964,536 | 27,056 | Shares | Sole | 2022-07-21 | |
| 2021-09-30 | $2,831,369 | 40,535 | Shares | Sole | 2022-07-26 | |
| 2021-06-30 | $2,620,260 | 38,052 | Shares | Sole | 2022-07-27 | |
| 2021-03-31 | $2,379,482 | 36,817 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $2,229,668 | 38,271 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $1,412,549 | 22,354 | Shares | Sole | 2022-07-28 | |
| No filing history on record for this holder in this stock. | ||||||